Indivior Plc lost three-quarters of the company’s stock market value and former parent Reckitt Benckiser also fell after the U.S. Justice Department accused the British drugmaker of illegally boosting prescriptions for the blockbuster opioid addiction treatment Suboxone.
Three drugmakers will pay $122.6 million to resolve claims they used charities that help cover Medicare patients’ out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of their medications.
Germany-based dialysis clinic operator Fresenius Medical Care AG will pay about $231 million to resolve criminal and civil allegations that the company paid bribes to public health and government officials in a variety of countries in order to win or retain business, the U.S. Justice Department.
A Missouri Supreme Court ruling on talc lawsuits could reduce the liability and number of large trials Johnson & Johnson faces over allegations the company’s talc products, including baby powder, cause cancer.
Johnson & Johnson received subpoenas from the U.S. Justice Department and the Securities and Exchange Commission related to litigation involving alleged asbestos contamination in the company’s signature Baby Powder product line.
The U.S. Justice Department filed a lawsuit seeking to stop a nonprofit in Philadelphia from opening what could become the nation’s first supervised drug-injection site in an effort aimed at addressing opioid abuse.
The former chief executive of Insys Therapeutics Inc. agreed to plead guilty to participating in a scheme to bribe doctors.
A unit of Johnson & Johnson will pay $360 million to resolve an investigation into the company’s financial support of a charity that helped Medicare patients cover out-of-pocket drug costs.
In an unusual move, a federal judge raised the prospect of not approving CVS Health Corp.’s deal to buy insurer Aetna Inc. – which has closed – during a routine portion of the legal process.
A former executive at Insys Therapeutics Inc. pleaded guilty to participating in a scheme to bribe doctors to prescribe the company’s powerful opioid medication and entered into a deal to cooperate with prosecutors.